Page last updated: 2024-09-04

3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione and Neurofibromatosis 2

3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione has been researched along with Neurofibromatosis 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adusumilli, PS; Bialik, A; Bodd, FM; Chang, JC; Chen, YB; Ladanyi, M; Li, Y; Lopardo, J; Offin, MD; Rusch, VW; Sauter, JL; Travis, WD; Yang, SR; Zauderer, MG1

Other Studies

1 other study(ies) available for 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione and Neurofibromatosis 2

ArticleYear
Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2023, Volume: 36, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Humans; Immunohistochemistry; Mesothelioma; Mesothelioma, Malignant; Neurofibromatosis 2; Neurofibromin 2; Transcription Factors; YAP-Signaling Proteins

2023